High Intensity Endurance Exercise as a Primer to Virtual Reality for Optimizing Cortical Excitability and Neuroplasticity in Parkinson's Disease (PD)

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to determine the effects of aerobic exercise as a primer to add-on virtual reality (VR)-based rehabilitation on balance, postural control and neuroplasticity (ability of brain to adapt in structure and function) in individuals with Parkinson's disease (PD). This study will utilize two groups - one group will receive the exercise and VR, while the other group will receive stretching exercise and VR over eight weeks. The study team will administer outcomes at baseline, post-intervention (8 weeks) and follow-up (6 weeks after post-assessment).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:

• Diagnosis of idiopathic PD (ages 18 -85) in Hoehn and Yahr stages 2 - 3.

• Subjects need to demonstrate a score of equal to or greater than 23 on the Mini Mental State Examination.

• Subjects who have a score of ≤21.5 on the Mini Balance Evaluations Systems Test (miniBESTest).

Locations
United States
Texas
UT Health San Antonio- Dept. of Physical Therapy
RECRUITING
San Antonio
Contact Information
Primary
Anjali Sivaramakrishnan, PhD
sivaramakris@uthscsa.edu
210-567-8626
Time Frame
Start Date: 2024-02-09
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 16
Treatments
Experimental: High intensity endurance exercise and virtual reality (experimental)
The exercise group will perform high intensity interval exercise and VR-based games 3 times a week for 8 weeks.
Other: Stretching and virtual reality (control)
The stretching group will perform stretching exercises and VR-based games 3 times a week for 8 weeks.
Related Therapeutic Areas
Sponsors
Collaborators: National Center for Advancing Translational Sciences (NCATS)
Leads: The University of Texas Health Science Center at San Antonio

This content was sourced from clinicaltrials.gov